{
  "image_filename": "table_p5_det_4_002.png",
  "image_path": "Grohskopf_et_al.__2023_/extracted/figures/table_p5_det_4_002.png",
  "image_type": "Table",
  "page_number": 5,
  "block_id": "det_4_002",
  "claim_id": "claim_002",
  "claim": "Cell- and egg-based flu vaccines have the potential to develop mutations during production, which may reduce their effectiveness.",
  "supports_claim": false,
  "explanation": "A table listing various influenza vaccines (trade name, manufacturer), their presentations (dosage forms and volumes), age indications, antigen content per dose, administration route, and mercury content. Vaccines are categorized by type: standard-dose egg-based inactivated (IIV4), cell culture\u2013based inactivated (ccIIV4), high-dose egg-based (HD-IIV4), egg-based with MF59 adjuvant (aIIV4), recombinant HA (RIV4), and live attenuated egg-based (LAIV4). does not support the claim because the table provides formulation and dosing details without any information on mutations arising during production or impact on vaccine effectiveness Note: The table text is clear and complete; no mention of mutations or effectiveness concerns is present.",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "A table listing various influenza vaccines (trade name, manufacturer), their presentations (dosage forms and volumes), age indications, antigen content per dose, administration route, and mercury content. Vaccines are categorized by type: standard-dose egg-based inactivated (IIV4), cell culture\u2013based inactivated (ccIIV4), high-dose egg-based (HD-IIV4), egg-based with MF59 adjuvant (aIIV4), recombinant HA (RIV4), and live attenuated egg-based (LAIV4).",
    "evidence_found": null,
    "reasoning": "does not support the claim because the table provides formulation and dosing details without any information on mutations arising during production or impact on vaccine effectiveness",
    "confidence_notes": "The table text is clear and complete; no mention of mutations or effectiveness concerns is present."
  }
}